Evidence map›Paper›PMID 36197656›Full record

ArticleJAMA surgery2022

Association of Patient Belief About Success of Antibiotics for Appendicitis and Outcomes: A Secondary Analysis of the CODA Randomized Clinical Trial.

Writing Group for the CODA Collaborative, Irene Y Zhang, Emily C Voldal, Giana H Davidson, Joshua M Liao, Callie M Thompson, Wesley H Self, Lillian S Kao, Jill Cherry-Bukowiec, Krishnan Raghavendran and 27 more

Erratum issued Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in JAMA surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02800785 (The Comparison of Outcomes of Antibiotic Drugs and Appendectomy), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02800785 nacompletednot on this map

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

TypeinterventionalSponsorUniversity of WashingtonRan2016 to 2021Enrolled1,552ConditionsAppendicitisArmsCefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid, Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin, Appendectomy
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 14 institutions in 1 country.

Writing Group for the CODA Collaborative
Irene Y ZhangDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Emily C VoldalDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Giana H DavidsonDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Joshua M LiaoDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Callie M ThompsonVanderbilt University Medical Center, Nashville, Tennessee.
Wesley H SelfVanderbilt University Medical Center, Nashville, Tennessee.
Lillian S KaoMcGovern Medical School, The University of Texas Health Science Center at Houston, Houston.
Jill Cherry-BukowiecMichigan Medicine, Ann Arbor.
Krishnan RaghavendranMichigan Medicine, Ann Arbor.
Amy H KajiHarbor-UCLA Medical Center, West Carson, California.
Daniel A DeUgarteHarbor-UCLA Medical Center, West Carson, California.
Eva GonzalezHarbor-UCLA Medical Center, West Carson, California.
Katherine A MandellThe Swedish Medical Center, Seattle, Washington.
Kristen OheThe Swedish Medical Center, Seattle, Washington.
Nicole SiparskyRush University Medical Center, Chicago, Illinois.
Thea P PriceRush University Medical Center, Chicago, Illinois.
David C EvansThe Ohio State University Wexner Medical Center, Columbus.
Jesse VictoryBellevue Hospital Center, NYU School of Medicine, New York, New York.
William ChiangTisch Hospital, NYU Langone Medical Center, New York, New York.
Alan JonesThe University of Mississippi Medical Center, Jackson.
Matthew E KutcherThe University of Mississippi Medical Center, Jackson.
Hailie CiomperlikLyndon B. Johnson General Hospital, University of Texas, Houston.
Mike K LiangLyndon B. Johnson General Hospital, University of Texas, Houston.
Heather L EvansHarborview Medical Center, UW Medicine, Seattle, Washington.
Brett A FaineUniversity of Iowa Hospitals and Clinics, Iowa City.
Miriam NeufeldBoston University Medical Center, Boston, Massachusetts.
Sabrina E SanchezBoston University Medical Center, Boston, Massachusetts.
Anusha KrishnadasanOlive View-UCLA Medical Center, Los Angeles, California.
Bryan A ComstockDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Patrick J HeagertyDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Sarah O LawrenceDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Sarah E MonsellDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Erin E C FannonDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Larry G KesslerDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
David A TalanOlive View-UCLA Medical Center, Los Angeles, California.
David R FlumDepartment of Surgery, Surgical Outcomes Research Center, University of Washington, Seattle.
Collaborative Group (United States) · USUniversity of Washington · USBoston University · USJackson Memorial Hospital · USMichigan Medicine · USRush University Medical Center · USHarbor–UCLA Medical Center · USMedical University of South Carolina · USSwedish Medical Center · USLyndon Baines Johnson Hospital · USNYU Langone Health · USThe Ohio State University Wexner Medical Center · USUniversity of Utah · USVanderbilt University Medical Center · US

Funding

Renewal: Gastrointestinal Surgery Outcomes Research FellowshipT32DK070555 · NIDDK · UNIVERSITY OF WASHINGTON · PI FLUM, DAVID R · 2010 to 2024
$3.6M
NIDDK NIH HHS T32 DK070555
6 · The paper itself

Abstract

Importance: A patient's belief in the likely success of a treatment may influence outcomes, but this has been understudied in surgical trials. Objective: To examine the association between patients' baseline beliefs about the likelihood of treatment success with outcomes of antibiotics for appendicitis in the Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial. Design, Setting, and Participants: This was a secondary analysis of the CODA randomized clinical trial. Participants from 25 US medical centers were enrolled between May 3, 2016, and February 5, 2020. Included in the analysis were participants with appendicitis who were randomly assigned to receive antibiotics in the CODA trial. After informed consent but before randomization, participants who were assigned to receive antibiotics responded to a baseline survey including a question about how successful they believed antibiotics could be in treating their appendicitis. Interventions: Participants were categorized based on baseline survey responses into 1 of 3 belief groups: unsuccessful/unsure, intermediate, and completely successful. Main Outcomes and Measures: Three outcomes were assigned at 30 days: (1) appendectomy, (2) high decisional regret or dissatisfaction with treatment, and (3) persistent signs and symptoms (abdominal pain, tenderness, fever, or chills). Outcomes were compared across groups using adjusted risk differences (aRDs), with propensity score adjustment for sociodemographic and clinical factors. Results: Of the 776 study participants who were assigned antibiotic treatment in CODA, a total of 425 (mean [SD] age, 38.5 [13.6] years; 277 male [65%]) completed the baseline belief survey before knowing their treatment assignment. Baseline beliefs were as follows: 22% of participants (92 of 415) had an unsuccessful/unsure response, 51% (212 of 415) had an intermediate response, and 27% (111 of 415) had a completely successful response. Compared with the unsuccessful/unsure group, those who believed antibiotics could be completely successful had a 13-percentage point lower risk of appendectomy (aRD, -13.49; 95% CI, -24.57 to -2.40). The aRD between those with intermediate vs unsuccessful/unsure beliefs was -5.68 (95% CI, -16.57 to 5.20). Compared with the unsuccessful/unsure group, those with intermediate beliefs had a lower risk of persistent signs and symptoms (aRD, -15.72; 95% CI, -29.71 to -1.72), with directionally similar results for the completely successful group (aRD, -15.14; 95% CI, -30.56 to 0.28). Conclusions and Relevance: Positive patient beliefs about the likely success of antibiotics for appendicitis were associated with a lower risk of appendectomy and with resolution of signs and symptoms by 30 days. Pathways relating beliefs to outcomes and the potential modifiability of beliefs to improve outcomes merit further investigation. Trial Registration: ClinicalTrials.gov Identifier: NCT02800785.

Indexed as

AppendicitisAdultAnti-Bacterial AgentsAppendectomyHumansMaleSurveys and QuestionnairesTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID36197656
PMCPMC9535504
OpenAlexW4302009540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.